Pharma Journalist -

CM Life Sciences II and SomaLogic, Inc., a leader in AI-data driven proteomics technology, and Twist Bioscience Corporation, a company enabling customers to succeed through its offering…
Read More...

SMi Group reports: 4th Annual Ophthalmic Drugs Conference taking place on the 22nd-23rd of November 2021, in London With 50% of the global population predicted to have complications…
Read More...

Pfizer Inc. and BioNTech SE announced that they have submitted Phase 1 data to the U.S. Food and Drug Administration (FDA) to support the evaluation of a third, or booster, dose of the…
Read More...

GlaxoSmithKline (GSK) plc announced the US Food and Drug Administration (FDA) approved a new indication for JEMPERLI (dostarlimab-gxly), a programmed cell death receptor-1 (PD-1)…
Read More...

HDT Bio Corp., a developer of immunotherapies for oncology and infectious diseases, announced an agreement with Korean biotech Quratis Inc. to co-develop HDT’s revolutionary COVID-19…
Read More...

Gritstone bio, Inc. a clinical-stage biotechnology company developing next generation cancer and infectious disease immunotherapies, announced that the company entered into a funding…
Read More...

Nexus Pharmaceuticals, Inc., a U.S.-based healthcare company and domestic pharmaceutical manufacturer, has received a patent covering applications of EMERPHED Ready-To-Use Ephedrine…
Read More...

Aurinia Pharmaceuticals Inc. announced the addition of two novel assets that will expand the Company’s rare autoimmune and kidney-related disease pipeline. “Over the past year, in…
Read More...

Virpax Pharmaceuticals, Inc. a company specializing in developing product candidates for pain management, CNS and anti-viral indications, today announced that it has received a written…
Read More...

Marrone Bio Innovations, Inc. an international leader in sustainable bioprotection and plant health solutions to support global agricultural needs, and Terramera, a global agtech leader…
Read More...